# ClinicalTrials.gov record NCT05709444

> PeptideScanner retained ClinicalTrials.gov record NCT05709444 at 2026-07-30T18:39:33.780Z. Its registry update date was 2024-10-17, and PeptideScanner's reviewed identity mapping was bremelanotide.

- Evidence object: `story:clinicaltrials-gov-nct05709444-bremelanotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2024-10-17
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-08
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct05709444-bremelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct05709444-bremelanotide-v1.json
- Content SHA-256: `15f2bfb2a9108e7d2d4813805baedfa70eabbc0e0942516228ae3c4cbd2bb67b`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT05709444 ([`ctg-observation-nct05709444-2024-10-17-355c6ec0c61a`](#source-ctg-observation-nct05709444-2024-10-17-355c6ec0c61a))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT05709444 at 2026-07-30T18:39:33.780Z. Its registry update date was 2024-10-17, and PeptideScanner's reviewed identity mapping was bremelanotide. ([`ctg-observation-nct05709444-2024-10-17-355c6ec0c61a`](#source-ctg-observation-nct05709444-2024-10-17-355c6ec0c61a))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT05709444 at 2026-07-30T18:39:33.780Z. Its registry update date was 2024-10-17, and PeptideScanner's reviewed identity mapping was bremelanotide. ([`ctg-observation-nct05709444-2024-10-17-355c6ec0c61a`](#source-ctg-observation-nct05709444-2024-10-17-355c6ec0c61a))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct05709444-2024-10-17-355c6ec0c61a`](#source-ctg-observation-nct05709444-2024-10-17-355c6ec0c61a))

## Sources

<a id="source-ctg-observation-nct05709444-2024-10-17-355c6ec0c61a"></a>
- **ClinicalTrials.gov record NCT05709444 · retained source version 2024-10-17:355c6ec0c61a08f2248f50ead340654fa4af8764c6912f671d11d5005be28de1** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT05709444) (`ctg-observation-nct05709444-2024-10-17-355c6ec0c61a`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT05709444." Version 1, published 2026-08-08. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct05709444-bremelanotide-v1.json SHA-256: 15f2bfb2a9108e7d2d4813805baedfa70eabbc0e0942516228ae3c4cbd2bb67b.